These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35142291)

  • 41. Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study.
    Barth S; Edwards C; Saini G; Haider Y; Williams NP; Storrar W; Jenkins G; Stewart I; Wickremasinghe M
    Respir Res; 2024 Apr; 25(1):162. PubMed ID: 38622608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study.
    Kerwin EM; Donohue JF; Ferguson GT; Ganapathy V; Ozol-Godfrey A; Rajagopalan K
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):24-33. PubMed ID: 30457433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
    Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
    Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study".
    Güder G; Brenner S; Angermann CE; Ertl G; Held M; Sachs AP; Lammers JW; Zanen P; Hoes AW; Störk S; Rutten FH
    Respir Res; 2012 Feb; 13(1):13. PubMed ID: 22309369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of RESP-FIT: Technology-Enhanced Self-Management Intervention for Adults with COPD.
    Miller S; Teufel R; Nichols M; Davenport P; Mueller M; Silverman E; Madisetti M; Pittman M; Kelechi T; Strange C
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3263-3273. PubMed ID: 34887656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
    Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Mobile Health Technology Use for Self-Tracking Between Older Adults and the General Adult Population in Canada: Cross-Sectional Survey.
    Jaana M; Paré G
    JMIR Mhealth Uhealth; 2020 Nov; 8(11):e24718. PubMed ID: 33104517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel App-Based Portable Spirometer for the Early Detection of COPD.
    Lin CH; Cheng SL; Wang HC; Hsu WH; Lee KY; Perng DW; Lin HI; Lin MS; Tsai JR; Wang CC; Lin SH; Wang CY; Chen CZ; Yang TM; Liu CL; Wang TY; Lin MC
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
    Lawson CA; Mamas MA; Jones PW; Teece L; McCann G; Khunti K; Kadam UT
    JAMA Netw Open; 2018 Dec; 1(8):e185489. PubMed ID: 30646293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease.
    Wootton SL; Dale MT; Tian Y; King M; Alison JA; Chan ASL; Varnfield M; Yang IA; McKeough ZJ
    Digit Health; 2024; 10():20552076241237381. PubMed ID: 38559582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fixed-dose combination of three drugs, i.e. LABA/LAMA/ICS for COPD: Results of a real-world study from India.
    Salvi S; Deb AK; Agarwal M; Tummuru VR; Kodgule R; Hemalatha VS; Awasthi AK; Suraj KP; Pavitran VK; Mourya SP; Thomas P; Vaidya A; Chhowala S; Gogtay J
    Pulm Pharmacol Ther; 2020 Aug; 63():101932. PubMed ID: 32777289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
    Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey.
    Solem CT; Sun SX; Liu S; Macahilig C; Katyal M; Gao X; Shorr AF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():991-8. PubMed ID: 25284999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated Telehealth and Telecare for Monitoring Frail Elderly with Chronic Disease.
    Gokalp H; de Folter J; Verma V; Fursse J; Jones R; Clarke M
    Telemed J E Health; 2018 Dec; 24(12):940-957. PubMed ID: 30129884
    [No Abstract]   [Full Text] [Related]  

  • 58. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
    Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
    Donohue JF; Kerwin E; Barnes CN; Moran EJ; Haumann B; Crater GD
    BMC Pulm Med; 2020 May; 20(1):134. PubMed ID: 32393215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation.
    Rudolf I; Pieper K; Nolte H; Junge S; Dopfer C; Sauer-Heilborn A; Ringshausen FC; Tümmler B; von Jan U; Albrecht UV; Fuge J; Hansen G; Dittrich AM
    JMIR Mhealth Uhealth; 2019 Nov; 7(11):e12442. PubMed ID: 31750841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.